MedTrace Logo

Meditation for Chemotherapy-Induced Nausea and Vomiting in Women With Breast Cancer

NCT07470619 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2026-03-13

No results posted yet for this study

Summary

This randomized clinical trial aimed to evaluate the effectiveness of Twin Hearts Meditation in reducing chemotherapy-induced nausea and vomiting among women with breast cancer undergoing chemotherapy. Chemotherapy-related nausea and vomiting are among the most distressing side effects of cancer treatment and can negatively affect patients' quality of life, nutritional status, and adherence to therapy.

The study focused on whether regular practice of this meditation technique could significantly reduce the severity of nausea and the frequency of vomiting episodes following chemotherapy. The main research questions were:

Does Twin Hearts Meditation reduce chemotherapy-induced nausea and vomiting among women with breast cancer? Can this complementary and non-invasive intervention be considered a supportive strategy for managing chemotherapy-related symptoms?

Participants were randomly assigned to either the intervention group, which practiced Twin Hearts Meditation, or the control group, which received routine care without meditation. The intervention group received a 30-minute guided meditation training session and practiced the meditation three times per week for two weeks.

Nausea severity and vomiting episodes were assessed using a nausea severity scale and a vomiting record flow sheet at baseline and at 6, 12, 18, and 24 hours after chemotherapy to evaluate the effectiveness of the intervention.

Conditions

  • Nausea and Vomiting Chemotherapy-Induced
  • Meditation Training

Interventions

BEHAVIORAL

Twin Heart Meditation

Participants in this group received Twin Hearts Meditation, a structured mind-body relaxation technique designed to promote emotional balance and psychological well-being. The intervention included a supervised 30-minute guided meditation session provided by a trained researcher in the chemotherapy unit. Participants were then instructed to continue the meditation practice at home for 30 minutes per session, at least three times per week for two weeks using an audio recording provided by the researcher. The meditation protocol included the following steps: * Light physical warm-up exercises to promote relaxation * Focused attention on positive emotions such as compassion and calmness * Guided meditation to promote mental relaxation and emotional balance * Silent concentration on a repeated phrase * Expression of gratitude * Closing relaxation exercises Regular telephone follow-up was conducted during the intervention period to support adherence to the meditation practice.

Sponsors & Collaborators

  • Near East University, Turkey

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-15
Primary Completion
2016-06-15
Completion
2016-06-30

Countries

  • Cyprus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07470619 on ClinicalTrials.gov